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Interferon regulatory factor 1-deficient (IRF-1/) mice infected with virulent Brucella abortus 2308 at 5 
105 CFU developed acute hepatitis similar to many natural hosts but, unlike natural hosts, IRF-1/ mice were
unable to resolve infection and died. In contrast, IRF-1/ mice survived when infected at 5  105 CFU with
several attenuated Brucella strains (S19, RB51, cbp, and cyd). The survival of infected IRF-1/ mice is likely
a function of the level of virulence of each Brucella strain and the extent of retained immunity. Further, these
findings suggest that adaptive immunity may be important to the survival of IRF-1/ mice since attenuated
Brucella strains can protect IRF-1/ mice against lethal challenge with virulent Brucella. Using the IRF-1/
mouse model, the following set of criteria were identified to define Brucella virulence: (i) the day of death for
50% of mice infected with 5  105CFU of Brucella, (ii) the extent of liver toxicity, and (iii) the minimum
immunizing dose of Brucella to protect against challenge with virulent S2308. Thus, IRF-1/ mice are
important to determining the level of Brucella virulence, to evaluating Brucella mutants for attenuation, and to
investigating adaptive immunity in brucellosis.
Brucella abortus, a gram-negative facultative intracellular
bacterium, is the etiologic agent of zoonotic brucellosis, whose
pathologic manifestations are hepatitis, arthritis, endocarditis,
and meningitis in humans and spontaneous abortion in cattle,
respectively (4, 7, 17). This airborne pathogen resides and
multiplies in macrophages of mammalian hosts and has been
used as a model to study immune response against intracellular
bacteria, as well as to investigate the mechanisms of intracel-
lular bacterial pathogenesis (25, 26, 27). Brucella virulence is
determined by infecting mice with various Brucella strains and
sequentially monitoring bacterial clearance from selected or-
gans, usually the liver and spleen (6, 9, 15a, 28).
Gamma interferon (IFN-) is a crucial cytokine in Brucella
immunity required for macrophage bactericidal activity (2). In
general, the diverse functions of IFN- are mediated by inter-
feron regulatory factors (IRFs), a family of secondary tran-
scriptional factors (18, 29). This family, which includes IRF-1
through IRF-8 and p48, is characterized by the unique “tryp-
tophan cluster” DNA-binding region located at the N termi-
nus. IRF-1 is strongly inducible by IFN-/ and IFN-, as well
as by tumor necrosis factor alpha (TNF-), and participates in
many IFN-specific signaling pathways. The immunobiology of
IRF-1 is elucidated by IRF-1/ mice. These mice are char-
acterized by a 90% reduction of CD8 T cells, functionally
impaired natual killer (NK) cells, and dysregulation of inter-
leukin-12 (IL-12) p40 and inducible nitric oxide synthase
(iNOS) induction, which are necessary to confer proper im-
mune protection. Thus, this mouse strain is useful for under-
standing the roles of IRF-1 during in vivo bacterial infections.
The clearance of Brucella from host tissues is often exam-
ined for at least 6 weeks because of the chronic nature of
brucellosis, and highly virulent strains can persist for at least 20
weeks (26). Further, the chronic nature of Brucella infection in
mice parallels the chronic nature of human infection (3, 20).
However, determining the virulence of several Brucella strains
based on the time of clearance from organs creates a formi-
dable labor-intensive challenge. Therefore, animal models that
would provide a rapid measure of Brucella virulence are
needed. Previously, we reported that IRF-1/ mice infected
with 5 105 CFU of virulent B. abortus S2308 died from severe
hepatic damage within 2 weeks postinfection, whereas RB51-
infected mice survived (Ko et al., unpublished), implying a
significant role for IRF-1 in Brucella immunity in vivo. How-
ever, the survival of IRF-1/ mice infected with 5  105 CFU
of the attenuated RB51 strain suggests that a certain level of
Brucella virulence is required to induce the death of IRF-1/
mice. IRF-1/ mice appear to have a level of basal immunity
necessary to control the infection.
No human vaccine exists against Brucella, and methods are
necessary to dissect Brucella pathogenesis to reach this vaccine
goal. A number of Brucella strains have been identified, but
readily available criteria to rapidly distinguish and rank the
level of virulence among Brucella strains are needed. Thus, the
rapid death of IRF-1/ mice infected with virulent Brucella,
in contrast to the survival of IRF-1/ mice infected with an
attenuated Brucella strain, suggests that IRF-1/ mice, as an
animal model, could be useful for detecting various degrees of
Brucella virulence. Here we have utilized the IRF-1/ mouse
to define the level of virulence of various Brucella strains.
The aim of the present study was to investigate both wild-
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type and mutant Brucella strains for virulence and thus define
the criteria for Brucella virulence. We also found that immu-
nologic memory can provide protection to IRF-1/ mice.
Here we report that the criteria of Brucella virulence among
several strains is based on the following factors: (i) the rapidity
of death in IRF-1/ mice infected with Brucella at 5  105
CFU, (ii) the extent of hepatic damage, and (iii) the protection
against Brucella virulence provided by immunizing IRF-1/
mice with an attenuated strain that induces an adaptive im-
mune response. The varying responses of IRF-1/ mice
against diverse Brucella strains as a function of different levels
of virulence suggests the importance of this mouse, as an an-
imal model, for dissecting bacterial pathogenesis by using at-
tenuated, gene-disrupted bacteria. In so doing, the immunobi-
ology of IRF-1/ mice will be clarified, thus increasing the
value of the mouse strain as an animal model.
MATERIALS AND METHODS
Bacterial strains. B. abortus S2308, the virulent wild-type strain, and S19, a live
attenuated previous U.S. vaccine strain, were kindly provided by Barbara Martin,
Veterinary Services, National Animal Disease Center, Ames, Iowa. RB51, the
current live attenuated U.S. vaccine strain, was a generous gift of Gerhardt G.
Schurig, Virginia-Maryland Regional College of Veterinary Medicine, Virginia
Polytechnic Institute and State University, Blacksburg, Va. B. abortus cyd (9) and
cbp (T. A. Ficht, unpublished data) insertional mutants (kanamycin resistant
[Kmr]) were provided by Thomas A. Ficht, and bap (Kmr) (15) deletion mutants
were produced as previously described.
Mice. A pair of IRF-1/ mice, originally produced by Matsuyama et al. (19)
by using C57BL/6 (H-2b) mice, was kindly donated by Tak W. Mak, Amgen
Institute, Ontario Cancer Institute, University of Toronto, Toronto, Ontario,
Canada. These mice strains were heterozygously bred in the Department of
Animal Health and Biomedical Sciences animal care facilities, and 6- to 9-week-
old mice were used for experimental infection. Prior to infection, IRF-1/ mice
were genotyped by PCR (26). Whenever possible, IRF-1/ mice derived from
heterozygous littermates were used as controls; otherwise, C57BL/6 (H-2b) mice
were used (Jackson Laboratory, Bar Harbor, Maine). Mice infected with Brucella
abortus were housed in a biosafety level 3 facility in the School of Veterinary
Medicine.
Infection and challenge of mice. IRF-1/ and IRF-1/ mice were injected
intraperitoneally with diverse strains and CFU of B. abortus in 200 l of phos-
phate-buffered saline (PBS). After 6 weeks of infection, surviving IRF-1/ mice
were challenged with 5 105 CFU of B. abortus S2308 in 200 l of PBS. Infected
IRF-1/ mice were monitored daily.
Enumeration of Brucella from spleens and livers. To count residual Brucella
CFU in the spleens or livers of mice, five mice from each group were examined
at each sampling period. Spleens or livers were homogenized in plastic bags with
10 ml of sterile PBS by using a Stomacher Lab Blender (Tekmar, Cincinnati,
Ohio). To enumerate viable Brucella, homogenized spleen or liver samples were
serially diluted 10-fold with PBS and plated on Brucella agar (Difco, Detroit,
Mich.). Brucella colonies were counted after a 3-day incubation at 37°C with 5%
CO2. Bacterial CFU at 100 per organ were not detected by this method.
GOT, GPT, and albumin assays. Mice were exsanguinated from the orbital
sinus and sera were collected by using Microtainer (Becton Dickinson, Ruther-
ford, N.J.). Glutamic oxalacetic transaminase (GOT) and glutamic pyruvic
transaminase (GPT) activities, as well as the albumin concentration, were quan-
titatively measured by colorimetric determination with diagnostic transaminase
reagents and albumin reagent (BCG), respectively, according to the manufac-
turer’s direction (Sigma, St. Louis, Mo.). The activities of GOT and GPT were
measured with 1:5 diluted sera with PBS.
Histology. Brucella-infected mice were killed 12 days postinfection. Organs
were immersed in 10% formalin, embedded, microsectioned, mounted on mi-
croscopic slides, and stained with hematoxylin and eosin. The hematoxylin and
eosin-stained slides were microscopically observed.
Statistical analysis. Data from infected mice were analyzed independently and
compared by using analysis of variance and the generalized Wilcoxon rank sum
test (Lifetest) in the SAS program (SAS Institute, Inc., Cary, N.C.). Infection of
IRF-1/ mice was performed twice independently, and then the results were
pooled to perform the data analysis. P values of 0.05 were considered signifi-
cant.
RESULTS
Survival of IRF-1/ mice infected with different CFU
counts of B. abortus S2308, S19, and RB51. Previously, we
reported that IRF-1/ mice respond to Brucella infection in a
death or survival manner, depending on the levels of virulence
among injected strains at 5  105 CFU (15a). This result
suggested that a certain level of virulence is required to induce
death in IRF-1/ mice and/or the basal immunity of IRF-
1/ mice can control the infection caused by an attenuated
strain. Thus, to establish criteria to determine virulence, the
response of IRF-1/ mice infected with selected doses of B.
abortus strains possessing different levels of virulence was in-
vestigated, and the results are summarized in Table 1. The
response of IRF-1/ mice was tested with three different B.
abortus strains; wild-type strain S2308, the previous vaccine
strain S19, and the current vaccine strain RB51. The differ-
ences in the virulence of these three strains have been well
elucidated in mice, and the apparent order of virulence is as
follows: S2308 	 S19 	 RB51 (2, 28).
Fifty percent of IRF-1/ mice injected with S2308 and S19
at 5  105 CFU died at 10 and 20 days postinoculation, re-
spectively, whereas IRF-1/ mice injected with the same dose
of RB51 survived the 4 weeks of infection (Fig. 1). Thus, the
life or death of the host induced by 5  105 CFU was depen-
dent on Brucella virulence. Similarly, S2308 and S19 at 5  107
CFU produced death of 50% of IRF-1/ mice between 6 to
7 days postinoculation, whereas the injection of the same CFU
of RB51 failed to induce death of IRF-1/ mice during the 4
weeks of infection (data not tabulated). All IRF-1/ mice
injected with 5  109 CFU of RB51 died 7 days later (data not
tabulated). In contrast, IRF-1/ mice injected with 5 101 or
5  103 CFU of S2308 and S19 survived infection (data not
tabulated). Similarly, S2308 and S19 at 5  107 and RB51 at 5
 109 CFU did not cause death of IRF-1/ mice (n 
 3 per
group) during the 4 weeks of infection (data not tabulated).
Taken together, the death or survival of IRF-1/ mice caused
by respective doses of Brucella is a unique feature that may be
related to the importance of the IRF-1 transcription factor in
activating critical host protective mechanisms (19, 24). Also,
these results indicate that the rapidity of death or the survival
of IRF-1/ mice is dependent on the dose and virulence of
TABLE 1. Protection of IRF-1/ mice against S2308a
B. abortus
strain
Immunized
CFU
% Protection (no. of animals
protected/total no.) at:
4 wk p.c. 8 wk p.c. 12 wk p.c.
None (PBS) 0 0 (0/10) Dead Dead
S19 5 101 80 (8/10) 80 (8/10) 80 (8/10)
S19 5 103 87.5 (7/8) 87.5 (7/8) 87.5 (7/8)
RB51 5 105 87.5 (7/8) 87.5 (7/8) 62.5 (5/8)
RB51 5 107 100 (9/9) 100 (9/9) 100 (9/9)
cyd mutant 5 105 80 (8/10) 60 (6/10) 40 (4/10)
cyd mutant 5 107 90 (9/10) 90 (9/10) 90 (9/10)
a IRF-1/ mice were immunized with different Brucella strains. At 6 weeks
after infection, mice in each group were challenged intraperitoneally with wild-
type B. abortus 2308. p.c., postchallenge.
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respective Brucella strains, and the injection of 5 105 CFU in
IRF-1/ mice can be an optimal bacterial concentration to
differentiate the level of virulence in B. abortus strains. In fact,
no RB51 (5  105 CFU)-infected mice died during the study,
and 50% of S2308 infected mice were dead by day 10. The
differences in the day postinfection when 50% of IRF-1/
mice were dead could be a useful indicator to identify the
degree of virulence (Table 1).
Enumeration of B. abortus CFU from liver and spleen of
S2308, S19, and RB51 infected IRF-1/ and IRF-1/ mice.
To correlate the level of virulence in B. abortus strains S2308,
S19, and RB51 with the outcome of infection, IRF-1/ mice
were infected with 5  105 CFU, and splenic Brucella CFU
counts were determined for 4 weeks. Infected IRF-1/ mice
had similar numbers of S2308 and S19 Brucella CFU during the
4 weeks of infection, although a statistically significant (P 
0.05) 1-log-higher amount of S19 was detected at 2 weeks
postinoculation (Fig. 2). In contrast, RB51-infected IRF-1/
mice contained a 3-log-lower bacterial CFU in the spleen com-
pared to S2308 and S19 infected mice after the first week of
infection. In subsequent weeks, RB51 colonies were difficult to
identify (Fig. 2).
IRF-1/ mice infected with virulent S2308 maintained a
1-log-greater bacterial CFU compared to infected IRF-1/
mice for the first 9 days, Fig. 3A. However, a 2-log difference
in bacteria at day 12 was observed between IRF-1/ and
IRF-1/ mice in the liver (Fig. 3A) but not in the spleen (Fig.
3B). In contrast, IRF-1/ and IRF-1/ mice infected with
attenuated RB51 had a similar pattern of hepatic bacterial
clearance, except that clearance in IRF-1/ mice was delayed
until day 12.
Clearance of attenuated RB51 from the spleens of IRF-1/
mice was more effective than clearance of virulent S2308 that
persisted for the 12 days of infection. However, IRF-1/ mice
maintained RB51 at 3.5 to 4 log CFU in the spleen for the 12
days postinfection compared to the rapid reduction of bacteria
in IRF-1/ mice (Fig. 3B).
Taken together, these results (Fig. 1 to 3) indicate that the
degree of virulence was S2308 	 S19 	 RB51, as determined
by CFU from the livers and spleens of IRF-1/ mice. Also,
virulence as determined by CFU correlated with the rapidity of
death of infected IRF-1/ mice in the order of S2308 	 S19
	 RB51.
Histologic and phenotypic analysis of Brucella-infected IRF-
1/ and IRF-1/ mice. Brucellosis induces chronic granu-
loma formation in the livers and spleens of humans and mice
(5, 15a, 17). To determine whether pathologic changes could
be detected with different strains of Brucella, IRF-1/ and
IRF-1/ mice were infected with 5  105 CFU of S2308 or
RB51. Mice were killed at day 12, tissues were histologically
examined, and consistent changes were noted in the livers.
S2308 induced more granulomas in the livers of IRF-1/ and
IRF-1/ mice than RB51 did (Fig. 4). Further, more exten-
sive multifocal granulomas were detected in IRF-1/ mice
compared to IRF-1/ mice (Fig. 4). These findings in IRF-
1/ mice indicate that the extent of liver damage caused by a
B. abortus strain correlates with the hepatic CFU burden of B.
abortus. Histologic analysis of brain, lung, heart, kidney,
spleen, genital, and gastrointestinal organs did not indicate
significant or consistent changes in these organs.
Interestingly, infected moribund IRF-1/ mice possessed a
very unique phenotype visually discernible from healthy, in-
fected IRF-1/ mice (Fig. 5). IRF-1/ mice infected with B.
abortus S2308 or S19 at 5  105 CFU contained 6 to 10 ml of
ascitic fluid, whereas the RB51 infected IRF-1/ mice did
not. These findings in IRF-1/ mice suggest that virulent
Brucella infection causes hepatic damage, leading to ascites
production, and the acquisition of ascitic fluid could be a key
clinical sign to detect the level of virulence in Brucella strains.
Survival of IRF-1/ and IRF-1/ mice infected with cyd,
cbp, and bap S2308 mutants. The survival or death of IRF-1/
mice infected with 5  105 CFU of S2308, S19, or RB51 (Fig.
1) and residual hepatic and splenic CFU in IRF-1/ mice
(Fig. 3) suggest that IRF-1/ mice may be useful for evalu-
ating the role in bacterial virulence of selected bacterial genes.
Using gene-deleted or gene-interrupted mutant bacteria, the
FIG. 1. Susceptibility of IRF-1/ mice (n 
 11 per group) to B.
abortus (5  105 CFU) S2308, S19, and RB51. Each symbol represents
a day. IRF-1/ mice infected with RB51 survived longer than S2308
(P  0.0001)- or S19 (P  0.0001)-infected mice. Mice infected with
S19 survived longer than S2308 (P  0.005)-infected mice.
FIG. 2. Infection of IRF-1/ mice with 5  105 CFU of S2308,
S19, and RB51. Five IRF-1/ mice were used for each time per group
for the enumeration of splenic Brucella CFU.
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importance of a given gene in bacterial virulence can be de-
termined. To test this possibility, three Brucella mutants (cyd,
cbp, and bap) were introduced. cyd (9) and cbp (Ficht, unpub-
lished) are gene-interrupted mutants of cytochrome d oxidase
and a calcium-binding protein, respectively, whereas bap (15)
is a gene-deletion mutant of an ATP-binding protein.
Importantly, when IRF-1/ mice were infected with the B.
abortus cbp and cyd mutants, 5  105 CFU of the cyd mutant
did not induce the death of IRF-1/ mice, but the cbp mutant
produced two deaths from 11 infected mice after 20 days posti-
noculation (Fig. 6A). Thus, the degree of attenuation in the
cbp mutant was not sufficient to prevent the death of IRF-1/
mice. In IRF-1/ mice, bap mutants induced death in 50% of
the mice 12 days after infection (Fig. 6A) compared to S2308
infection that induced the death of 50% of IRF-1/ mice at
10 days. However, this discrepancy was not statistically signif-
icant.
Taken together, these results indicate that IRF-1/ mice
infected with cyd or cbp mutants survived longer than when
infected with S2308 (P 0.0001). IRF-1/ mice infected with
the bap mutant survived as long as mice infected with S2308.
Thus, the level of virulence from Brucella mutants, as reflected
in CFU in the spleens of IRF-1/ mice, is compatible with
virulence as defined by the rapidity of death in IRF-1/ mice
infected with 5  105 CFU of S2308, S19, or RB51.
Enumeration of CFU from liver and spleen of IRF-1/ and
IRF-1/ mice infected with cyd, cbp, and bap S2308 mutants.
Infection of IRF-1/ and IRF-1/ mice with S2308 revealed
a persistent increase in bacterial CFU in the livers of IRF-1/
mice compared to those of IRF-1/ mice (Fig. 3).
To determine the clearance of cyd, cbp, and bap S2308 mu-
tants from mice, splenic B. abortus CFU were first counted
from IRF-1/ mice after infection with these mutants at 5 
105 CFU (Fig. 6B). The cyd gene-interrupted mutant was
rarely detected in spleens after 2 weeks postinfection from the
spleens. CFU detected from mice infected with the cbp gene-
interrupted mutant had a 1-log difference compared to S2308-
infected mice during the 4 weeks of infection. The parental
S2308 and cbp mutant had statistically different (P  0.05)
CFU at all weeks examined (Fig. 6B). In contrast to cyd and
cbp mutants, no significant difference in CFU of bacteria from
spleens was detected between the bap mutant and its parental
strain during the 4 weeks of infection in IRF-1/ mice. Thus,
the apparent order of virulence detected by splenic CFU in
IRF-1/ mice was S2308 
 bap 	 cbp 	 cyd 
 RB51.
To determine whether hepatic damage from bap, cbp, and
cyd mutants correlated with the criteria for virulence with
S2308, S19, and RB51 in IRF-1/ mice, IRF-1/ and IRF-
1/ mice were infected with these mutants, and Brucella CFU
were enumerated from livers (Fig. 7A) and spleens (Fig. 7B) at
the moribund stage or 4 weeks after infection. Twelve days
after bap mutant injection, a 3.5-log CFU difference in livers
and a 1-log CFU difference in spleens was detected between
IRF-1/ and IRF-1/ mice. These results coincide with re-
sults in Fig. 3 with S2308-infected IRF-1/ and IRF-1/
mice, confirming that hepatic bacterial burden correlates with
the death of IRF-1/ mice. At 4 weeks after cbp mutant
injection, 4 logs of bacterial CFU were detected in the livers of
IRF-1/ mice, whereas no B. abortus were detected from the
livers of IRF-1/ mice (Fig. 7A), suggesting that residual
basal immunity in IRF-1/ mice may control cbp infection.
Additionally, a 2-log CFU difference in the cbp mutant was
detected from the spleens of IRF-1/ and IRF-1/ mice
(Fig. 7B). The hepatic bacterial burden induced by cbp mutants
in IRF-1/ mice at 4 weeks after infection was 3 logs less than
the CFU detected from bap- or S2308-infected IRF-1/ mice
at the moribund stage. No cyd mutant was detected from the
livers or spleens of IRF-1/ or IRF-1/ mice at 4 weeks after
infection. Therefore, these results support a correlation be-
tween hepatic bacterial burden and the death of IRF-1/
mice and suggest that a level of virulence equivalent to that of
S2308 is required to produce death in IRF-1/ mice.
Biochemical analysis of hepatic damage in IRF-1/ mice.
The existence of ascitic fluid (Fig. 5), as well as the hepatic
bacterial burden in IRF-1/ mice infected with virulent Bru-
cella strains (Fig. 6A), suggests progression of liver damage.
Because livers from IRF-1/ mice infected with B. abortus
strain S2308 had marked granulomas (Fig. 4), GOT, GPT, and
albumin concentrations in sera were measured to quantify the
level of hepatic damage at the moribund stage or 4 weeks
FIG. 3. IRF-1/ and IRF-1/ mice infected with B. abortus virulent S2308 and attenuated RB51 (5 105 CFU) strains for 12 days. The extent
of bacteria recovered from liver (A) and spleen (B) indicated a 2.5-log reduction of S2308 from the livers of IRF-1/ mice compared to IRF-1/
mice at day 12 (P  0.0005). Clearance of RB51 occurred in the livers of IRF-1/ and IRF-1/ mice.
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postinoculation (Fig. 8). Both uninfected IRF-1/ and IRF-
1/ mice maintained a normal GOT and GPT activity in
serum (37 and 19 IU/liter, respectively [data not shown]) (23).
Also, IRF-1/ and IRF-1/ mice infected with cyd mutants
did not have increased GOT and GPT activities in sera at 4
weeks postinoculation. In contrast, bap- and cbp-infected IRF-
1/ and IRF-1/ mice possessed increased GOT (Fig. 8A)
and GPT (Fig. 8B) activities at the moribund stage, indicating
that acute hepatitis occurred in both mouse strains. However,
the extent of liver damage between the two mouse strains was
evident with a twofold increase in IRF-1/ mice and a four-
fold-increased GOT and GPT levels in IRF-1/ mice. These
results suggest that 4 weeks of cbp mutant infection generates
hepatic damage similar to that induced by S2308 (Fig. 3 and 4)
or bap mutants at 12 days postinoculation, suggesting that the
death of cbp-infected IRF-1/ mice may occur after 4 weeks
postinoculation. In fact, two more mice were dead after the
FIG. 4. Histopathology of livers from IRF-1/ and IRF-1/ mice infected with 5  105 CFU of S2308 or RB51. IRF-1/ mice infected with
S2308 had more extensive multifocal granulomas than infected IRF-1/ mice (arrows). RB51-infected IRF-1/ and IRF-1/ mice had similar
infrequent lymphoid aggregates.
FIG. 5. Ascites of 5  105 CFU S2308-infected IRF-1/ mice at
day 12 compared to RB51-infected mice. A total of 6 to 10 ml of fluid was
typically in the abdomen. Cells in the fluid were 	90% macrophages.
7008 KO ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
4-week study, and many mice were not healthy (data not
shown). Taken together, these GOT and GPT results indicate
virulence-dependent hepatic damage occurred in both mouse
strains, but the level of hepatic damage in IRF-1/ mice was
more severe than in IRF-1/ mice.
The existence of ascitic fluid (6 to 10 ml/mouse) in IRF-1/
mice infected with the bap mutant suggests that the concen-
tration of albumin in sera may have been low since albumin is
an osmotic regulator produced by the liver (13). Both unin-
fected (data not shown) and cyd-infected IRF-1/ and IRF-
1/ mice maintained normal levels of serum albumin (3.4
g/dl; Fig. 8C) (23). However, bap mutant-infected IRF-1/
and IRF-1/ mice had a 29 and a 53% reduction in albumin,
indicating that the disruption of osmotic regulation occurred in
both mouse strains. cbp mutant-infected IRF-1/ and IRF-
1/ mice showed a 35% reduction in albumin only in IRF-
1/ mice (Fig. 8C).
As a result, GOT and GPT, as well as albumin, assays iden-
tified serious liver damage and disruption of osmotic regulation
in IRF-1/ mice infected with the bap mutant at the moribund
stage, less-serious liver damage in IRF-1/ mice infected with
the cbp mutant at 4 weeks, and no hepatic damage in IRF-1/
mice infected with the cyd mutant at 4 weeks postinoculation.
These results suggest that death in IRF-1/ mice involves
liver damage and that a certain level of bacterial virulence is
required to induce liver damage in IRF-1/ mice.
FIG. 6. (A) Survival of IRF-1/ mice (n 
 11) infected with mutant Brucella (bap, cbp, and cyd) or S2308. Mice infected with cyd or cbp
mutants survived longer than S2308-infected mice (P  0.0001). However, bap mutant infection was not statistically significant. (B) Growth of
mutant Brucella (bap, cbp, and cyd) compared to S2308 in the spleens of infected IRF-1/ mice. Five IRF-1/ mice were used for each time per
group. Each symbol represents a day.
FIG. 7. Hepatic (A) and splenic (B) Brucella CFU from IRF-1/ mice compared to IRF-1/ mice infected with B. abortus cbp, cyd, and bap
mutants (5  105 CFU). Mice were at the moribund stage or 4 weeks postinoculation. Hepatic bap CFU detected from IRF-1/ and IRF-1/
mice showed a 3.5-log difference at 12 days postinoculation (P  0.005), indicating the serious bacterial burden in IRF-1/ mice. No difference
in bacterial growth was noted in the spleens of IRF-1/ and IRF-1/ mice. However, attenuated cbp and cyd mutants were controlled by
IRF-1/ mice at 4 weeks postinoculation.
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Brucella dose- and virulence-dependent protection in immu-
nized IRF-1/ mice. IRF-1/ mice were immunized with
selected Brucella strains at sublethal doses for 6 weeks and
challenged with the lethal dose (5  105 CFU) of S2308. All
IRF-1/ mice immunized with any Brucella strain survived
longer than nonimmunized IRF-1/ mice, suggesting that
immunological memory exists and can provide protection (Ta-
ble 2). In addition, two major results were noticed. First, in
terms of Brucella strains possessing the same level of virulence,
higher doses of immunization provide better protection. For
example, IRF-1/ mice immunized with RB51 or cyd mutants
at 5  107 CFU provided twofold greater protection than mice
immunized with 5  105 CFU. Second, the more attenuated
the Brucella strain, the higher the dose of immunization re-
quired to provide protection. For instance, IRF-1/ mice
immunized with S19 at 5  103 CFU provided similar protec-
tion to IRF-1/ mice immunized with RB51 or cyd mutants at
5  107 CFU. These results indicate that IRF-1/ mice main-
tain an adaptive immunological memory necessary for protec-
tion, and protection in IRF-1/ mice is dependent on the
level of bacterial virulence and the dose of immunization.
DISCUSSION
Human brucellosis is a chronic, undulating disease, and cur-
rently there is no human vaccine. Thus, there is a need to rank
the virulence of mutant Brucella that might serve as potential
vaccine candidates. Mice have been used to determine Brucella
virulence since the chronic nature of Brucella infection in mice
parallels the chronic nature of human infection (3, 20). How-
ever, such studies are complicated by the need to monitor
bacterial clearance from organs for at least 6 weeks, requiring
large numbers of mice to frequently sample for bacteria, and
such experiments are labor-intensive. Therefore, animal mod-
els that provide a rapid measure of Brucella virulence are
needed.
The IRF-1/ mouse provides a useful set of three criteria
used to define virulence in brucellosis; these are summarized in
Table 1. First, the day when 50% of IRF-1/ mice die after
injection of 5 105 CFU of bacteria is an important indication
of virulence. The more rapidly the death occurs, the greater
the bacterial virulence. Second, the extent of liver damage, e.g.,
the presence of granulomas, the liver transaminase activity,
and the hepatic CFU bacterial count supports the virulence of
the Brucella strain. Third, the minimum immunizing dose for
protection against challenge with virulent S2308 (5  105
CFU) indicates the decreased virulence of the immunizing
strain, as well as its ability to induce immune protection.
IRF-1/ mice provide a new animal model to analyze the
contribution of individual Brucella genes to bacterial virulence.
Using several Brucella gene-deleted or gene-interrupted mu-
tants, we applied these virulence criteria to three engineered
mutant Brucella to evaluate the contribution of individual bac-
terial genes to virulence. Thus, bacterial CFU in spleens and
livers as well as the length of survival of IRF-1/ mice in-
FIG. 8. GOT (A) and GPT (B) activity and albumin concentration
(C) assays. Sera were collected from IRF-1/ and IRF-1/ mice
infected with cbp, cyd, and bap mutants (5  105 CFU) at the mori-
bund stage or 4 weeks postinoculation. The levels of increased GOT
and GPT activities and decreased albumin concentration in sera from
bap or cbp mutant-infected IRF-1/ mice were discernible from bap
or cbp mutant-infected IRF-1/ mice and cyd-infected IRF-1/
mice, indicating serious liver damage in bap mutant-infected IRF-1/
mice at the moribund stage or in cbp mutant-infected IRF-1/ mice
at 4 weeks postinoculation.
TABLE 2. Criteria for Brucella strain virulence in IRF-1/ mice
Criterion
Brucella strain virulence
Low Intermediate High
Days of survivala RB51, cyd S19, cbp S2308, bap
Liver featuresb RB51, cyd S19, cbp S2308, bap
Protectionc RB51, cyd S19 S2308
a That is, the day when 50% of the mice were alive after infection with 5  105
CFU of a Brucella strain. Fifty percent of mice surviving for 30 days is low, 19 to
25 days is intermediate, and  18 days is high virulence.
b Combined changes in albumin, hepatic GOT, GPT, and hepatic granuloma
formation.
c Survival of vaccinated IRF-1/ mice for 6 weeks after challenge with S2308
at 5  105 CFU. Low virulence is 	90% of mice surviving, intermediate viru-
lence is 60 to 89% of mice surviving, and high virulence is 50% of mice
surviving.
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fected with different brucellae can be used to dissect the mech-
anisms of virulence as a component of bacterial pathogenesis.
Our initial observation regarding the acute death of IRF-
1/ mice by strain S2308 but not by strain RB51 suggests that
IRF-1/ mice respond to B. abortus strains differently de-
pending on the level of virulence in each strain (15a). Thus, a
certain level of bacterial virulence is required to induce the
death of IRF-1/ mice, and/or a basal level of immunity
remains in IRF-1/ mice sufficient to control infection caused
by an attenuated bacterial strain such as RB51. Therefore, we
explored bacterial pathogenesis with diverse Brucella strains
containing various levels of virulence in IRF-1/ mice.
Three different experiments were performed in IRF-1/
mice to investigate each of three criteria for virulence. First,
dose-dependent responses of IRF-1/ mice against B. abortus
S2308, S19, and RB51 strains were investigated, and 5  105
CFU was identified as an optimized amount to differentiate
IRF-1/ mouse survival or death induced by a Brucella strain
(Fig. 1) and bacterial clearance from organs (Fig. 2). Second,
using genetically identified bap, cbp, and cyd B. abortus mu-
tants containing distinctive levels of persistence in vitro (15)
and in vivo (9, 15), the application of IRF-1/ mice to detect
virulence was tested (Fig. 4). Third, the correlation between
the level of virulence and the level of hepatic damage was
determined by measuring the hepatic bacterial CFU and
transaminase activities, as well as the albumin concentration in
serum at either the moribund stage or 4 weeks postinoculation,
suggesting that death in IRF-1/ mice is associated with he-
patic damage (Fig. 3, 5, and 6). Together, these results suggest
that the level of Brucella virulence can be determined by IRF-
1/ mouse survival and that the level of Brucella virulence
correlates with bacterial CFU and level of hepatic damage, as
reflected by transaminase and albumin levels in serum.
One manifestation of human brucellosis is acute hepatitis (8,
17). Most human beings or animals infected with Brucella
overcome this acute hepatitis and maintain a chronic infection,
and this transition is dependent on the virulence of Brucella
strains and the induction of an adaptive immune response (4,
17). However, in some cases, human brucellosis results in
death. For example, humans with Brucella peritonitis and liver
problems, such as alcoholism or hepatitis virus infection, con-
tain ascites and can die if proper treatment does not follow (1,
5, 22, 30). Similarly, in IRF-1/ mice in which hepatitis occurs
in the absence of important adaptive immune components,
animals infected with virulent strain 2308 are unable to control
infection. IRF-1/ mice infected with the virulent strain died
within 12 days, supporting the role of IRF-1 as essential for
host immunity to Brucella; however, the defective immune
components in IRF-1/ mice that contribute to Brucella sus-
ceptibility are unknown. In IRF-1/ mice, the host immune
mechanisms that fail to control hepatic damage caused by
virulent Brucella require further experiments.
In contrast to lethality when IRF-1/ mice were infected
with Brucella S2308, IRF-1/ mice infected with attenuated
Brucella strains did not die, supporting the possibility that
IRF-1/ mice have a level of adaptive immunity that may
protect these mice. Additional studies are required to confirm
the relationship between Brucella virulence and dose-depen-
dent immune protection in IRF-1/ mice. Survival of IRF-
1/ mice was unexpected since this mouse strain is deficient
in IL-12 p40 induction that is required for a Th1 immune
response against many intracellular pathogens (18, 29). We
hypothesize Kupffer cells may not control virulent Brucella
because the levels of IFN- and TNF- in IRF-1/ mice are
lower than in wild-type mice (26). Insufficient levels of IFN-
and TNF- may not activate phagocytic activity of Kupffer
cells, permitting continued B. abortus proliferation in the liver.
The death of IRF-1/ mice after virulent Brucella infection
is a unique feature in brucellosis because even SCID (21) and
nude (6) mice control Brucella infection. IRF-1/ mice are
deficient in CD8 T cells and NK cells, as well as in the
induction of IL-12, p40, and iNOS (18, 29). This phenotypically
well-characterized mouse strain has been used to investigate
the role of IRF-1 or the role of defective immune components
during infection. For example, IRF-1/ mice are susceptible
to Mycobacterium bovis BCG (12), Leishmania major (16), and
Toxoplasma gondii (14) due to the absence of iNOS induction
and/or IL-12 p40 induction but are resistant to Listeria mono-
cytogenes (11) infection. The death of IRF-1/ mice infected
with T. gondii has been reported previously, but the dose- and
virulence-dependent death and the cause of death have not
been investigated. Thus, the susceptibility of IRF-1/ mice
appears to be pathogen specific.
IRF-1/ mice can serve as a useful animal for evaluating
mutant brucellae. We have identified Brucella promoters and
associated genes activated early in macrophage infection (10).
Now, using targeted gene disruption, IRF-1/ mice can be
used to determine the association of these bacterial genes with
virulence in the process of bacterial pathogenesis.
In summary, we have demonstrated that virulence can be
defined by (i) the rapidity of death in IRF-1/ mice infected
with 5  105 CFU; (ii) the level of hepatic damage detected by
the increased hepatic bacterial burden, as well as transaminase
and albumin assays; and (iii) dose-dependent immune protec-
tion against virulent Brucella challenge can be engendered in
IRF-1/ mice by attenuated Brucella strains. These results
suggest that the application of IRF-1/ mice to brucellosis
research will aid in the understanding of this host-pathogen
interaction. Further, IRF-1/ mice, as an animal model, pro-
vide a rapid assessment of Brucella virulence that is useful for
screening large numbers of Brucella strains. In addition, IRF-
1/ mice will contribute to defining the adaptive immune
components and molecular mechanisms of immunity required
for protection. Defined criteria for virulence combined with a
rapid screening mouse model, the IRF-1/ mouse, will facil-
itate the development of novel vaccines.
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